Teva Joins Fight To Revoke Xarelto Patent
Teva has filed a fresh claim in a London court to invalidate a key patent tied to Bayer's blockbuster blood-thinner Xarelto, the second generic drugmaker in recent months to challenge the...To view the full article, register now.
Already a subscriber? Click here to view full article